

![]()


Clinical Research Organisation (CRO) Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031

Request Sample Report


The Clinical Research Organisation (CRO) market is witnessing robust growth, driven by increasing demand for outsourced clinical trials and rising R&D expenditures. The global CRO market is projected to reach approximately $69 billion by 2027, reflecting a compound annual growth rate (CAGR) of around 7%. Enhanced regulatory support fuels market expansion. Request Sample Report

◍ Charles River Laboratories
◍ IQVIA
◍ LabCorp
◍ Domainex
◍ Evotec AG
◍ Genscript Biotech
◍ GVK Biosciences
◍ Aurobindo Pharma
◍ Eurofins Scientific
◍ Reprocell
◍ Dalton Pharma
◍ NovAliX
◍ Jubilant Biosys
◍ Lupin Pharmaceuticals
◍ Piramal Pharma
◍ Sun Pharmaceutical
◍ Sai Ganga Panakeia
The CRO market features leading companies like Charles River Laboratories, IQVIA, and LabCorp, providing essential research services to pharmaceuticals and biotech firms. Their expertise enhances drug development efficiency. For example, IQVIA reported over $12 billion revenue, while LabCorp's revenue exceeded $14 billion, fueling overall market growth.

◍ Vitas Pharma
Request Sample Report


Pharmaceutical Company
Research Institute
Other
Request Sample Report
Small molecules
Biologics



Request Sample Report
$ X Billion USD












